XML 53 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2013
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
6.STOCK-BASED COMPENSATION

The Company has stock option and incentive arrangements to attract and retain key personnel. In May 2005, the 2005 Equity Compensation Plan (the “Plan”) was approved by the shareholders, which authorizes the issuance of restricted stock, stock appreciation rights, stock units and stock options to the Board of Directors and key employees. Compensation expense for service based awards is recognized over the vesting period. Performance based awards are recognized based on a vesting, if applicable, and the probability of achieving the goals.

 

Stock-based compensation expense totaled $134,305 and $65,522 for the three months ended March 31, 2013 and 2012, respectively, which consisted of grants of restricted stock and restricted stock units. Stock-based compensation for the three months ended March 31, 2013 and 2012 included director compensation of $3,320 and $6,807, respectively, for stock granted in lieu of cash compensation. All outstanding options are fully vested and the Company has not granted any stock options since 2007.

 

The fair value of the Company’s employee stock options granted is estimated on the date of grant using the Black-Scholes option pricing model. The Company estimates expected market price volatility and expected term of the options based on historical data and other factors.

 

The exercise price for options granted is set at the discretion of the committee administering the Plan, but is not less than the market value of the shares as of the date of grant. An option’s maximum term is 10 years and the options vest at the discretion of the committee.

 

The following tables below summarize outstanding and exercisable options at March 31, 2013 and December 31, 2012.

 

     Weighted     Weighted-Average 
     Average  Aggregate  Contractual Life 
     Exercise  Intrinsic  Remaining In 
  Shares  Price  Value  Years 
             
Outstanding at January 1, 2013  236,059  $18.49  $164,304     
Granted at fair value  -   -         
Exercised  (2,518)  13.19   10,248     
Expired  -   -         
Forfeited  (1)  13.19         
                 
Outstanding at March 31, 2013  233,540  $18.55  $225,938   1.0 
                 
Exercisable at March 31, 2013  233,540  $18.55  $225,938   1.0 

 

     Weighted     Weighted-Average 
     Average  Aggregate  Contractual Life 
     Exercise  Intrinsic  Remaining In 
  Shares  Price  Value  Years 
             
Outstanding at January 1, 2012  264,156  $17.90  $175,911     
Granted at fair value  -   -         
Exercised  (24,780)  12.25   88,607     
Expired  -   -         
Forfeited  (3,317)  18.25         
                 
Outstanding at December 31, 2012  236,059  $18.49  $164,304   1.0 
                 
Exercisable at December 31, 2012  236,059  $18.49  $164,304   1.0 

 

Options outstanding are all currently exercisable and are summarized as follows:

 

Number Outstanding  Weighted Average Weighted Average 
March 31, 2013  Remaining Contractual Life Exercise Price 
       
 49,340  1 years $12.94 
 82,651  2 years  15.89 
 80,138  3 years  22.29 
 21,411  5 years  27.70 
 233,540    $18.55 

  

The aggregate intrinsic value of outstanding stock options and exercisable stock options was $225,938 and $164,304 at March 31, 2013 and December 31, 2012, respectively. Aggregate intrinsic value represents the difference between the Company’s closing stock price on the last trading day of the period, which was $16.50 and $15.98 at March 31, 2013 and December 31, 2012, respectively, and the exercise price multiplied by the number of options outstanding.

 

The Company has outstanding restricted stock and stock units granted in accordance with the Plan. The following tables summarize the unvested restricted stock awards and units outstanding at March 31, 2013 and December 31, 2012, respectively.

 

  Restricted Stock  Restricted Stock Units 
  Number of
Shares
  Weighted
 Average Grant 
Date Fair Value
  Number of
Units
  Fair Value 
             
Nonvested at January 1, 2013  23,569  $15.64   5,211  $15.98 
Granted  13,656   18.00   2,105   16.87 
Vested  (16,678)  16.35   (3,106)  15.98 
                 
Nonvested at March 31, 2013  20,547  $16.63   4,210  $16.50 

 

  Restricted Stock  Restricted Stock Units 
  Number of
Shares
  Weighted
 Average Grant 
Date Fair Value
  Number of
Units
  Fair Value 
             
Nonvested at January 1, 2012  8,113  $16.47   6,845  $15.00 
Granted  23,281   15.21   2,105   15.98 
Vested  (7,825)  15.20   (3,739)  14.80 
                 
Nonvested at December 31, 2012  23,569  $15.64   5,211  $15.98